REFERENCES
- Sieg A, Arab L, Schlierf G, Stiehl A, Die KB. Pravalenz des Gilbert-syndromes in Deutschland. Dtsch Med Wochenschr 1987; 112(31/32):1206–1208.
- Schwertner HA, Vitek L. Gilbert syndrome, UGT1A1*28 allele, and cardiovascular disease risk: possible protective effects and therapeutic applications of bilirubin. Atherosclerosis 2008; 198(1):1–11.
- Bilirubin KJ. An endogenous product of heme degradation with both cytotoxic and cytoprotective properties. Mol Pharmacol 2004; 66(4):773–779.
- Djousse L, Levy D, Cupples LA, Evans JC, D’Agostino RB, Ellison RC. Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study. Am J Cardiol 2001; 87(10):1196–1200.
- Temme E, Zhang J, Schouten E, Kesteloot H. Serum bilirubin and 10-year mortality risk in a Belgian population. Cancer Caus Control 2001; 12(10):887–894.
- Troughton JA, Woodside JV, Young IS, . Bilirubin and coronary heart disease risk in the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Eur J Cardiovasc Prev Rehabil 2007; 14(1):79–84.
- Erdogan D, Gullu H, Yildirim E, . Low serum bilirubin levels are independently and inversely related to impaired flow-mediated vasodilation and increased carotid intima-media thickness in both men and women. Atherosclerosis 2006; 184(2):431–437.
- Novotny L, Vitek L.Inverse relationship between serum bilirubin and atherosclerosis in men: a meta-analysis of published studies. Exp Biol Med 2003; 228(5):568–571.
- Perlstein TS, Pande RL, Beckman JA, Creager MA. Serum total bilirubin level and prevalent lower-extremity peripheral arterial disease. Arterioscler Thromb Vasc Biol 2008; 28(1):166–172.
- Kostis JB, Lawrence-Nelson J, Ranjan R, Wilson AC, Kostis WJ, Lacy CR. Association of increased pulse pressure with the development of heart failure in sheep. Am J Hypertens 2001; 14(8): 798–803.
- Heitzer T, Schlinzig T, Krohn K, Meinertz T, Munzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001; 104(22):2673–2678.
- Rauchschwalbe SK, Zuhlsdorf MT, Schuhly U, Kuhlmann J. Predicting the risk of sporadic elevated bilirubin levels and diagnosing Gilbert’s syndrome by genotyping UGT1A1*28 promoter polymorphism. Int J Clin Pharmacol Ther 2002; 40(6): 233–240.
- Stocker R, Yamamoto Y, McDonagh A, Glazer A, Ames B. Bilirubin is an antioxidant of possible physiological importance. Science 1987; 235(4792):1043–1046.
- Abraham NG, Kappas A. Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev 2008; 60(1):79–127.
- Clark JE, Foresti R, Sarathchandra P, Kaur H, Green CJ, Motterlini R. Heme oxygenase-1-derived bilirubin ameliorates postischemic myocardial dysfunction. AJP - Heart and Circ Physiol 2000; 278(2):H643–H651.
- Leopold JA, Loscalzo J. Oxidative risk for atherothrombotic cardiovascular disease. Free Radic Biol Med 2009; 47(12):1673–1706.
- Esper RJ, Nordaby RA, Vilarino JO, Paragano A, Cacharron JL, Machado RA. Endothelial dysfunction: a comprehensive appraisal. Cardiovasc Diabetol 2006; 5:4.
- Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 2004; 109(23 Suppl 1):III27–III32.
- Lieberman EH, Gerhard MD, Uehata A, . Flow-induced vasodilation of the human brachial artery is impaired in patients <40 years of age with coronary artery disease. Am J Cardiol 1996; 78(11):1210–1214.
- Qureshi G, Brown R, Salciccioli L, . Relationship between aortic atherosclerosis and non-invasive measures of arterial stiffness. Atherosclerosis 2007; 195(2):e190–e194.
- Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 2000; 87(10):840–844.
- Maruhashi T, Soga J, Fujimura N, . Hyperbilirubinemia, augmentation of endothelial function, and decrease in oxidative stress in Gilbert syndrome. Circulation 2012; 126(5):598–603.
- Vitek L, Jirsa M, Brodanova M, . Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels. Atherosclerosis 2002;160(2):449–456.
- Yesilova Z, Serdar M, Ercin CN, . Decreased oxidation susceptibility of plasma low density lipoproteins in patients with Gilbert’s syndrome. J Gastroenterol Hepatol 2008; 23(10):1556–1560.